GanglioneuroblastomaSymptoms, Doctors, Treatments, Advances & More
Learn About Ganglioneuroblastoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Orthopaedics Clinic At Lauritzen Outpatient Center
Sean Mcgarry is an Orthopedics provider practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 28 years. Dr. Mcgarry is rated as a Distinguished provider by MediFind in the treatment of Ganglioneuroblastoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Osteosarcoma, Myxoid Liposarcoma, and Hip Replacement.
Advocate Lutheran General Cancer Institute
Pamela Kaiser is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Kaiser is rated as an Advanced provider by MediFind in the treatment of Ganglioneuroblastoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Endoscopy. Dr. Kaiser is board certified in American Board Of Internal Medicine, Medical Oncology.
Aurora Orthopedics
Nicholas Webber is an Orthopedics provider practicing medicine in Milwaukee, Wisconsin. Dr. Webber is rated as an Advanced provider by MediFind in the treatment of Ganglioneuroblastoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Osteoarthritis, Osteonecrosis, Rhabdomyosarcoma Embryonal, Hip Replacement, and Knee Replacement. Dr. Webber is board certified in American Board Of Orthopaedic Surgery.
Summary: This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found on the surface of neur...
Summary: This illustrative Phase 1/Phase 2 study tests allogeneic dual-target GD2/B7-H3 (CD276) CAR-NK cells in children and young adults with relapsed or refractory neuroblastoma. After lymphodepletion, participants receive IV CAR-NK cells;Part A defines the RP2D and Part B estimates preliminary activity